CSIMarket
 

Mesa Laboratories Inc  (NASDAQ: MLAB)
    Sector  Technology    Industry IT Infrastructure
   Industry IT Infrastructure
   Sector  Technology

Mesa Laboratories Inc's

Competitiveness




 

MLAB Sales vs. its Competitors Q1 2026







Revenue Growth Comparisons




Net Income Comparison




<<  MLAB Stock Performance Comparisons


Mesa Laboratories Inc's Comment on Competition and Industry Peers


Our products compete across several industries with a variety of companies, many of which are well established, with substantially greater capital resources and larger research and development capabilities. Furthermore, many of these companies have established product lines and a significant operating history. Accordingly, we may be at a competitive disadvantage with some competitors due to their respective size and market presence.

Companies with which our Instruments Division products compete include the Myron L Company, IBP Medical GmbH, Amphenol Corporation, Ellab, TMI Orion, Danaher, Inc., Thermo Fisher Scientific, Inc., Mecmesin, Steinfurth, Met One Instruments, Inc. and Tisch Environmental. Our Biological Indicators Division products compete with 3M, Terragene, NAMSA and Steris, among others. Our Continuous Monitoring Division systems compete with Rees Scientific Corporation, Amphenol Corporation and Cooper-Atkins, among others.



*Market share is calculated based on total revenue.

  News about Mesa Laboratories Inc Contracts

Mesa Laboratories Commitment to Financial Accuracy: Audit Delay Reflects Companys Int...

May 31, 2024
Mesa Laboratories, Inc. (Mesa) (NASDAQ:MLAB), a leading global provider of quality control solutions, has announced a delay in the release of its unaudited fourth-quarter and full fiscal year 2024 financial results. The delay is due to ongoing efforts by the company to finalize its year-end audit, which is primarily focused on completing the calculations and technical accounting related to impairments of long-lived assets and goodwill in its Clinical Genomics and Biopharmaceutical Development divisions. Additionally, the audit will also address the purchase accounting associated with the recent acquisition of GKE.Originally scheduled for release today, Mesa Laboratories aims to ensure the accuracy and comple...

Mesa Labs Sustains Commitment to Responsible Business Practices with Second Annual ESG Program Brochure

March 15, 2024
In a bid to reinforce its dedication to ethical and sustainable business practices, Mesa Laboratories, Inc. has unveiled its second annual Environmental, Social, and Governance (ESG) Program Brochure. With a focus on protecting vulnerable communities and fostering environmental stewardship, social responsibility, and strong corporate governance, Mesa Labs is positioning itself as a global leader in responsible business initiatives.Driven by the belief that businesses have a crucial role to play in safeguarding the planet and its population, Mesa Labs ESG initiatives have been integrated into its core values. The release of the comprehensive brochure showcases the company s ongoing efforts to embed sustainab...





Publicly Traded Peers of Mesa Laboratories Inc



Sources: Mesa Laboratories Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Mesa Laboratories Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.